Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Hospitals

 

“Bar code everything” policy helps control quality and cost; private sector takes note

An initiative around barcoding all theatre items and personnel has helped UK NHS Hospital Trusts monitor and control quality at the consultant and product-level and achieve nearly double-digit savings on theatre spend. We speak to the organisation supplying the initiative's data standards, which says private sector hospitals are increasingly interested in initiatives like it.

Health care service write-offs drive losses at Bupa

Bupa, the global healthcare insurer and healthcare operator went from pre-tax profits of £502m in 2018 to a loss of £78m in 2019, thanks mainly to huge write-offs in its UK dentistry business and Australian care homes. But stripping out write-offs, underlying profitability still plunged 31%. Revenue rose just 4%. Why, and what does this tell us about Bupa and its future?

EIT Health starts to map data sources

Most attempts at innovation in healthcare are still being built with insufficient access to the data that defines the problem. The EU's health innovation arm, EIT Health, is calling for providers to be more data transparent for the sake of policymakers and entrepreneurs. HBI speaks to its CEO and director of innovation about curating data.

COVID-19: Threats and opportunities

Covid-19 is going to have a huge impact on for-profit healthcare services. In the first of a two-part report, we look at what that will be at a sector and country level. Digital health looks like being a winner, Ping An claims online consultations are up tenfold, with the spectre of a crash in elective procedures hanging over for-profit hospitals and specialist outpatient chains. We also look at the likely impact on M&A.  The second part of this report, focussing on the care sector, will be published next week.

Asklepios moves on Rhoen – but is offer generous enough?

Germany's second-largest private hospital group Asklepios plans to launch a takeover of listed competitor Rhoen Klinikum in partnership with Rhoen's founder Eugene Muench. But Rhoen's shares have now risen above the offer price indicating this is far from a done deal.

Investors for Health opens door to all serious emerging market investors

All emerging market health-care investors are welcome to join Investors for Health (I4H), a newish community of 30+ investors including development banks, private equity, venture capital and impact funds. The group aims to jointly focus on private healthcare development in emerging markets with a focus on equity and alignment with universal healthcare cover. It next meets at HBI 2020, April 20-22, London. Its formation reflects a quiet revolution in the role of for-profit healthcare and its importance in bridging the World Health Organisation's estimated $686bn funding gap in low-and-middle-income countries to achieve the United Nation’s Sustainable Development Goal #3 (“Ensure healthy lives and promote well-being for all at all ages”).

Interview: Andrey Yanovsky, CEO, European Medical Center

HBI talks to the CEO of Moscow-based hospital operator European Medical Center (EMC), Andrey Yanovsky. He discusses its recent investment by a Russian billionaire, working with the state insurance fund and EMC's IPO prospects. 

Ameos acquires Swiss non-profit hospital

PE backed Swiss hospital and psychiatric group Ameos has acquired a majority stake in a not-for-profit hospital, its second facility in the country. The group, predominantly present in Germany and Austria, is taking advantage of a challenging climate in the Swiss hospital sector which is putting many small hospitals in financial trouble.

SRL shifts focus to B2C as minority sale stalls

Fortis-owned Indian lab chain SRL says that after the last two years of "stagnant expansion" it has started to open more blood collection points in a shift to the B2C segment. The company remains tight-lipped about the ongoing minority sale process.

Find Us